Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/07/2026 | Q1 | $1.3M | -- | -- | -$0.56 | -- |
| 02/26/2026 | Q4 | $76.9K | -- | -$0.51 | -$0.64 | $0.13 |
| 11/06/2025 | Q3 | $3.1M | $10M | -$0.39 | -$0.61 | $0.22 |
| 08/07/2025 | Q2 | $272.7K | -- | -$0.55 | -$0.47 | -$0.08 |
| 05/08/2025 | Q1 | $650K | -- | -$0.38 | -$0.39 | $0.01 |
| 12/31/2024 | Q4 | $1.3M | -- | -$0.36 | -$0.45 | $0.10 |
| 11/06/2024 | Q3 | $1.6M | $439K | -$0.51 | -$0.36 | -$0.16 |
| 08/07/2024 | Q2 | $863.1K | $8.9M | -$0.11 | -$0.29 | $0.18 |
| 05/08/2024 | Q1 | $1M | $1.3M | -$0.30 | -$0.33 | $0.03 |
| 03/08/2024 | Q4 | $739.3K | $2.5M | -$0.25 | -$0.39 | $0.14 |
| 11/07/2023 | Q3 | $845.5K | $2.5M | -$0.25 | -$0.43 | $0.18 |
| 08/08/2023 | Q2 | -- | $1.1M | -$0.42 | -- | -- |
| 05/09/2023 | Q1 | -- | $2M | -$0.42 | -- | -- |
| 03/10/2023 | Q4 | -- | $2.8M | -$0.39 | -- | -- |
| 11/10/2022 | Q3 | -- | $1.8M | -$0.40 | -- | -- |
| 08/09/2022 | Q2 | -- | $2.4M | -$0.41 | -- | -- |
| 05/10/2022 | Q1 | -- | $1.6M | -$0.32 | -- | -- |
| 03/18/2022 | Q4 | -- | $1.6M | -$0.33 | -- | -- |
| 11/09/2021 | Q3 | -- | $1.2M | -$0.26 | -- | -- |
| 08/10/2021 | Q2 | -- | $482K | -$0.15 | -- | -- |
| 03/31/2021 | Q1 | -- | $380K | -$0.05 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.04 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.03 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.06 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.03 | -- | -- |
Janux Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
Janux Therapeutics, Inc. announced earnings per share of -$0.51 which represents a beat of analyst forecast a -$0.64 per share.
Janux Therapeutics, Inc. reported -$468K that represents -$0.01 per share over the last quarter.
Janux Therapeutics, Inc.'s earnings are forecast to decrease from -$1.83 per share to -$1.97 per share next year representing a decrease of -41.04%.
Janux Therapeutics, Inc.'s next earnings date is May 7, 2026.
Signup to receive the latest stock alerts
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Since January 28th, software stocks in the United States have…
Over the last five days, shares of Instagram and Facebook…
Market Cap: $4.4T
P/E Ratio: 37x
Market Cap: $3.7T
P/E Ratio: 34x
Market Cap: $3.7T
P/E Ratio: 28x
American Public Education, Inc. [APEI] is up 26.24% over the past day.
Papa John's International, Inc. [PZZA] is down 5.25% over the past day.
Nebius Group NV [NBIS] is up 0.87% over the past day.